Announced Wed, 8 Jul · 12:05 IST
Natco to raise Adcock Ingram stake to 49% for Rupees 1069 crores
NATCOPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.2%1-day move
₹983.15
prior close
₹977.40
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2-0.2+0.1+1.1-2.2+0.0-0.4-1.1-1.4-3.9————
Up moveDown movePending
AI summary
Natco Pharma board approved acquiring additional shares in South Africa's Adcock Ingram Holdings at about Rupees 5.89 per share, raising its stake from 35.75% to 49% for around Rupees 1,069 crores. Separately, board approved investing up to Rupees 1,400 crores in its South African wholly owned subsidiary. Adcock Ingram posted US dollar 423 million topline in 9 months to March 2026. Post deal, Natco will book 49% of Adcock Ingram's profit after tax, strengthening its Africa footprint.
Likely market impact
Africa expansion with meaningful profit contribution; combined capital outlay of about Rupees 2,469 crores.